.png)
Therapeutic Vaccines Market by Product Type and Technology - Global Industry Analysis & Forecast to 2027
Published On : April 2020 Pages : 170 Category: Pharma & Healthcare Report Code : HC0410364
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Therapeutic Vaccines Market by Product Type (Addiction Vaccines, Autoimmune Disease Vaccines, Infectious Disease Vaccines, Neurological disease vaccines) Technology (Allogeneic Vaccine, Autologous Vaccine) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Therapeutic Vaccines Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Therapeutic vaccine is a type of vaccine which is administered after the disease or infection occurred to a patient. It works by activating immune system of the patient to fight towards infection. The therapeutic vaccines are mostly against viral infections. The patients affected with chronic viral infections are administered with therapeutic vaccines, as their immune system is not able to produce enough efficient antibodies.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
-
- Affiris
- Antigenics
- Argos Therapeutics
- Bavarian Nordic
- Biovest International
- Celldex Therapeutics
- Cel-Sci
- Celtic Pharma
- Curevac
- Cytos Biotechnology.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Therapeutic Vaccines Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Addiction Vaccines
o Autoimmune Disease Vaccines
o Infectious Disease Vaccines
o Neurological disease vaccines
· Therapeutic Vaccines Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)
o Allogeneic Vaccine
o Autologous Vaccine
· Therapeutic Vaccines Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Affiris
o Antigenics
o Argos Therapeutics
o Bavarian Nordic
o Biovest International
o Celldex Therapeutics
o Cel-Sci
o Celtic Pharma
o Curevac
o Cytos Biotechnology
· Therapeutic Vaccines Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Submarine Cables Market, By Country
o U.S. Submarine Cables Market
o Canada Submarine Cables Market
o Mexico Submarine Cables Market
o Europe
§ Europe Submarine Cables Market, By Country
o Germany Submarine Cables Market
o UK Submarine Cables Market
o France Submarine Cables Market
o Russia Submarine Cables Market
o Italy Submarine Cables Market
o Rest of Europe Submarine Cables Market
o Asia-Pacific
§ Asia-Pacific Submarine Cables Market, By Country
o China Submarine Cables Market
o Japan Submarine Cables Market
o South Korea Submarine Cables Market
o India Submarine Cables Market
o Southeast Asia Submarine Cables Market
o Rest of Asia-Pacific Submarine Cables Market
o South America
§ South America Submarine Cables Market
o Brazil Submarine Cables Market
o Argentina Submarine Cables Market
o Columbia Submarine Cables Market
o Rest of South America Submarine Cables Market
o Middle East and Africa
§ Middle East and Africa Submarine Cables Market
o Saudi Arabia Submarine Cables Market
o UAE Submarine Cables Market
o Egypt Submarine Cables Market
o Nigeria Submarine Cables Market
o South Africa Submarine Cables Market
o Rest of MEA Submarine Cables Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Therapeutic Vaccines Market, By Product Type
5.1. Introduction
5.2. Global Therapeutic Vaccines Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global Therapeutic Vaccines Revenue and Revenue Share by Product Type (2017-2021)
5.3. Addiction Vaccines
5.3.1. Global Addiction Vaccines Revenue and Growth Rate (2017-2021)
5.4. Autoimmune Disease Vaccines
5.4.1. Global Autoimmune Disease Vaccines Revenue and Growth Rate (2017-2021)
5.5. Infectious Disease Vaccines
5.5.1. Global Infectious Disease Vaccines Revenue and Growth Rate (2017-2021)
5.6. Neurological disease vaccines
5.6.1. Global Neurological disease vaccines Revenue and Growth Rate (2017-2021)
6. Therapeutic Vaccines Market, By Technology
6.1. Introduction
6.2. Global Therapeutic Vaccines Revenue and Market Share by Technology (2017-2021)
6.2.1. Global Therapeutic Vaccines Revenue and Revenue Share by Technology (2017-2021)
6.3. Allogeneic Vaccine
6.3.1. Global Allogeneic Vaccine Revenue and Growth Rate (2017-2021)
6.4. Autologous Vaccine
6.4.1. Global Autologous Vaccine Revenue and Growth Rate (2017-2021)
7. Therapeutic Vaccines Market, By Region
7.1. Introduction
7.2. Global Therapeutic Vaccines Revenue and Market Share by Regions
7.2.1. Global Therapeutic Vaccines Revenue by Regions (2017-2021)
7.3. North America Therapeutic Vaccines by Countries
7.3.1. North America Therapeutic Vaccines Revenue and Growth Rate (2017-2021)
7.3.2. North America Therapeutic Vaccines Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Therapeutic Vaccines by Countries
7.4.1. Europe Therapeutic Vaccines Revenue and Growth Rate (2017-2021)
7.4.2. Europe Therapeutic Vaccines Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Therapeutic Vaccines by Countries
7.5.1. Asia-Pacific Therapeutic Vaccines Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Therapeutic Vaccines Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Therapeutic Vaccines by Countries
7.6.1. South America Therapeutic Vaccines Revenue and Growth Rate (2017-2021)
7.6.2. South America Therapeutic Vaccines Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Therapeutic Vaccines by Countries
7.7.1. Middle East and Africa Therapeutic Vaccines Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Therapeutic Vaccines Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Affiris
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Antigenics
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Argos Therapeutics
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Bavarian Nordic
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Biovest International
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Celldex Therapeutics
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Cel-Sci
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Celtic Pharma
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Curevac
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Cytos Biotechnology
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Therapeutic Vaccines Market Forecast (2022-2027)
9.1. Global Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Therapeutic Vaccines Market Forecast by Regions (2022-2027)
9.2.1. North America Therapeutic Vaccines Market Forecast (2022-2027)
9.2.1.1. United States Therapeutic Vaccines Market Forecast (2022-2027)
9.2.1.2. Canada Therapeutic Vaccines Market Forecast (2022-2027)
9.2.1.3. Mexico Therapeutic Vaccines Market Forecast (2022-2027)
9.2.2. Europe Therapeutic Vaccines Market Forecast (2022-2027)
9.2.2.1. Germany Therapeutic Vaccines Market Forecast (2022-2027)
9.2.2.2. France Therapeutic Vaccines Market Forecast (2022-2027)
9.2.2.3. UK Therapeutic Vaccines Market Forecast (2022-2027)
9.2.2.4. Russia Therapeutic Vaccines Market Forecast (2022-2027)
9.2.2.5. Italy Therapeutic Vaccines Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Therapeutic Vaccines Market Forecast (2022-2027)
9.2.3. Asia-Pacific Therapeutic Vaccines Market Forecast (2022-2027)
9.2.3.1. China Therapeutic Vaccines Market Forecast (2022-2027)
9.2.3.2. Japan Therapeutic Vaccines Market Forecast (2022-2027)
9.2.3.3. Korea Therapeutic Vaccines Market Forecast (2022-2027)
9.2.3.4. India Therapeutic Vaccines Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Therapeutic Vaccines Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Therapeutic Vaccines Market Forecast (2022-2027)
9.2.4. South America Therapeutic Vaccines Market Forecast (2022-2027)
9.2.4.1. Brazil Therapeutic Vaccines Market Forecast (2022-2027)
9.2.4.2. Argentina Therapeutic Vaccines Market Forecast (2022-2027)
9.2.4.3. Columbia Therapeutic Vaccines Market Forecast (2022-2027)
9.2.4.4. Rest of South America Therapeutic Vaccines Market Forecast (2022-2027)
9.2.5. Middle East and Africa Therapeutic Vaccines Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Therapeutic Vaccines Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Therapeutic Vaccines Market Forecast (2022-2027)
9.2.5.3. Egypt Therapeutic Vaccines Market Forecast (2022-2027)
9.2.5.4. Nigeria Therapeutic Vaccines Market Forecast (2022-2027)
9.2.5.5. South Africa Therapeutic Vaccines Market Forecast (2022-2027)
9.2.5.6. Turkey Therapeutic Vaccines Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Therapeutic Vaccines Market Forecast (2022-2027)
9.3. Therapeutic Vaccines Market Forecast by Product Type (2022-2027)
9.3.1. Therapeutic Vaccines Forecast by Product Type (2022-2027)
9.3.2. Therapeutic Vaccines Market Share Forecast by Product Type (2022-2027)
9.4. Therapeutic Vaccines Market Forecast by Technology (2022-2027)
9.4.1. Therapeutic Vaccines Forecast by Technology (2022-2027)
9.4.2. Therapeutic Vaccines Market Share Forecast by Technology (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Therapeutic Vaccines Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Therapeutic Vaccines Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Addiction Vaccines Revenue and Growth Rate (2017-2019)
Figure Global Autoimmune Disease Vaccines Revenue and Growth Rate (2017-2019)
Figure Global Infectious Disease Vaccines Revenue and Growth Rate (2017-2019)
Figure Global Neurological disease vaccines Revenue and Growth Rate (2017-2019)
Table Global Therapeutic Vaccines Revenue and Revenue Share by Technology (2017-2019)
Figure Global Allogeneic Vaccine Revenue and Growth Rate (2017-2019)
Figure Global Autologous Vaccine Revenue and Growth Rate (2017-2019)
Table Global Therapeutic Vaccines Revenue by Regions (2017-2019)
Figure North America Therapeutic Vaccines Growth Rate (2017-2019)
Figure North America Therapeutic Vaccines Revenue and Growth Rate (2017-2019)
Figure North America Therapeutic Vaccines by Countries (2017-2019)
Figure North America Therapeutic Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure United States Therapeutic Vaccines Growth Rate (2017-2019)
Figure United States Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Therapeutic Vaccines Growth Rate (2017-2019)
Figure Canada Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Therapeutic Vaccines Growth Rate (2017-2019)
Figure Mexico Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Therapeutic Vaccines Growth Rate (2017-2019)
Figure Europe Therapeutic Vaccines Revenue and Growth Rate (2017-2019)
Figure Europe Therapeutic Vaccines by Countries (2017-2019)
Figure Europe Therapeutic Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure Germany Therapeutic Vaccines Growth Rate (2017-2019)
Figure Germany Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Therapeutic Vaccines Growth Rate (2017-2019)
Figure France Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Therapeutic Vaccines Growth Rate (2017-2019)
Figure UK Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Therapeutic Vaccines Growth Rate (2017-2019)
Figure Russia Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Therapeutic Vaccines Growth Rate (2017-2019)
Figure Italy Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Therapeutic Vaccines Growth Rate (2017-2019)
Figure Rest of Europe Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Therapeutic Vaccines Growth Rate (2017-2019)
Figure Asia-Pacific Therapeutic Vaccines Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Therapeutic Vaccines by Countries (2017-2019)
Figure Asia-Pacific Therapeutic Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure China Therapeutic Vaccines Growth Rate (2017-2019)
Figure China Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Therapeutic Vaccines Growth Rate (2017-2019)
Figure Japan Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Therapeutic Vaccines Growth Rate (2017-2019)
Figure Korea Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Therapeutic Vaccines Growth Rate (2017-2019)
Figure India Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Therapeutic Vaccines Growth Rate (2017-2019)
Figure Southeast Asia Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Therapeutic Vaccines Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Therapeutic Vaccines Growth Rate (2017-2019)
Figure South America Therapeutic Vaccines Revenue and Growth Rate (2017-2019)
Figure South America Therapeutic Vaccines by Countries (2017-2019)
Figure South America Therapeutic Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Therapeutic Vaccines Growth Rate (2017-2019)
Figure Brazil Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Therapeutic Vaccines Growth Rate (2017-2019)
Figure Argentina Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Therapeutic Vaccines Growth Rate (2017-2019)
Figure Columbia Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Therapeutic Vaccines Growth Rate (2017-2019)
Figure Rest of South America Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Therapeutic Vaccines Growth Rate (2017-2019)
Figure Middle East and Africa Therapeutic Vaccines Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Therapeutic Vaccines by Countries (2017-2019)
Figure Middle East and Africa Therapeutic Vaccines Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Therapeutic Vaccines Growth Rate (2017-2019)
Figure Saudi Arabia Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Therapeutic Vaccines Growth Rate (2017-2019)
Figure United Arab Emirates Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Therapeutic Vaccines Growth Rate (2017-2019)
Figure Egypt Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Therapeutic Vaccines Growth Rate (2017-2019)
Figure Nigeria Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Therapeutic Vaccines Growth Rate (2017-2019)
Figure South Africa Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Therapeutic Vaccines Growth Rate (2017-2019)
Figure Turkey Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Therapeutic Vaccines Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2017-2019)
Table Affiris Therapeutic Vaccines Financial Overview
Table Antigenics Therapeutic Vaccines Financial Overview
Table Argos Therapeutics Therapeutic Vaccines Financial Overview
Table Bavarian Nordic Therapeutic Vaccines Financial Overview
Table Biovest International Therapeutic Vaccines Financial Overview
Table Celldex Therapeutics Therapeutic Vaccines Financial Overview
Table Cel-Sci Therapeutic Vaccines Financial Overview
Table Celtic Pharma Therapeutic Vaccines Financial Overview
Table Curevac Therapeutic Vaccines Financial Overview
Table Cytos Biotechnology Therapeutic Vaccines Financial Overview
Figure Global Therapeutic Vaccines Revenue (Millions USD) and Growth Rate (2019-2027)
Table Therapeutic Vaccines Market Forecast by Regions (2019-2027)
Figure North America Therapeutic Vaccines Market Forecast (2019-2027)
Figure United States Therapeutic Vaccines Market Forecast (2019-2027)
Figure Canada Therapeutic Vaccines Market Forecast (2019-2027)
Figure Mexico Therapeutic Vaccines Market Forecast (2019-2027)
Figure Europe Therapeutic Vaccines Market Forecast (2019-2027)
Figure Germany Therapeutic Vaccines Market Forecast (2019-2027)
Figure France Therapeutic Vaccines Market Forecast (2019-2027)
Figure UK Therapeutic Vaccines Market Forecast (2019-2027)
Figure Russia Therapeutic Vaccines Market Forecast (2019-2027)
Figure Italy Therapeutic Vaccines Market Forecast (2019-2027)
Figure Rest of Europe Therapeutic Vaccines Market Forecast (2019-2027)
Figure Asia-Pacific Therapeutic Vaccines Market Forecast (2019-2027)
Figure China Therapeutic Vaccines Market Forecast (2019-2027)
Figure Japan Therapeutic Vaccines Market Forecast (2019-2027)
Figure Korea Therapeutic Vaccines Market Forecast (2019-2027)
Figure India Therapeutic Vaccines Market Forecast (2019-2027)
Figure Southeast Asia Therapeutic Vaccines Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Therapeutic Vaccines Market Forecast (2019-2027)
Figure South America Therapeutic Vaccines Market Forecast (2019-2027)
Figure Brazil Therapeutic Vaccines Market Forecast (2019-2027)
Figure Argentina Therapeutic Vaccines Market Forecast (2019-2027)
Figure Columbia Therapeutic Vaccines Market Forecast (2019-2027)
Figure Rest of South America Therapeutic Vaccines Market Forecast (2019-2027)
Figure Middle East and Africa Therapeutic Vaccines Market Forecast (2019-2027)
Figure Saudi Arabia Therapeutic Vaccines Market Forecast (2019-2027)
Figure United Arab Emirates Therapeutic Vaccines Market Forecast (2019-2027)
Figure Egypt Therapeutic Vaccines Market Forecast (2019-2027)
Figure Nigeria Therapeutic Vaccines Market Forecast (2019-2027)
Figure South Africa Therapeutic Vaccines Market Forecast (2019-2027)
Figure Turkey Therapeutic Vaccines Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Therapeutic Vaccines Market Forecast (2019-2027)
Figure Global Therapeutic Vaccines Forecast by Product Type (2019-2027)
Figure Global Therapeutic Vaccines Market Share Forecast by Product Type (2019-2027)
Figure Global Therapeutic Vaccines Forecast by Product Type (2019-2027)
Figure Global Therapeutic Vaccines Forecast by Technology (2019-2027)
Figure Global Therapeutic Vaccines Market Share Forecast by Technology (2019-2027)
Figure Global Therapeutic Vaccines Forecast by Technology (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|